Key Financial Data Of Reporting Company

Modalis Therapeutics Corporation - Filing #7337841

Concept 2024-01-01 to
2024-03-31
As at
2024-03-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-03-31
As at
2023-03-31
Key financial data of reporting company
Business results of reporting company
Ordinary profit (loss)
-457,445,000 JPY
-2,351,788,000 JPY
-509,905,000 JPY
Net assets
1,011,664,000 JPY
1,380,422,000 JPY
2,653,772,000 JPY
Total assets
1,559,124,000 JPY
2,025,925,000 JPY
2,899,423,000 JPY
Basic earnings (loss) per share
-13.57
-77.24
-17.86
Diluted earnings per share
Equity-to-asset ratio
0.629 xbrli:pure
0.668 xbrli:pure
0.909 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.